Noticias de JAGX_US

29/04/2026 JAGX_US — Yahoo Finance

Jaguar Health Announces Statistically Significant Results from Effectiveness Trial of Crofelemer (FDA Approved Canalevia-CA1) for Treatment of Chemotherapy-Induced Diarrhea in Dogs

28/04/2026 JAGX_US — The Post-Crescent

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

28/04/2026 JAGX_US — The Globe and Mail

Jaguar Health Enacts Reverse Split to Maintain Nasdaq Listing

27/04/2026 JAGX_US — Investing.com Nigeria

Jaguar Health receives Nasdaq extension, plans 1-for-35 reverse split

27/04/2026 JAGX_US — Yahoo Finance ES ← EN

Jaguar Health concedió una prórroga hasta el 15 de mayo de 2026 para demostrar el cumplimiento de la regla de precio de oferta del Nasdaq; La empresa anuncia división de acciones inversa

División inversa aprobada en la Asamblea Especial de Accionistas de abril de 2026 Las acciones ordinarias de Jaguar Health comenzarán a cotizar sobre una base ajustada dividida el 30 de abril de 2026 SAN FRANCISCO, CA / ACCESS Newswire / 27 de abril de 2026 /Jaguar Health, Inc. (Nasdaq:JAGX)...

27/04/2026 JAGX_US — Quantisnow

Jaguar Health Granted Extension Until May 15, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule; Company Announces Reverse Stock Split

27/04/2026 JAGX_US — Investing.com Canada

Jaguar Health receives Nasdaq extension, plans 1-for-35 reverse split

27/04/2026 JAGX_US — The Chronicle-Journal

User

27/04/2026 JAGX_US — Yahoo Finance

Jaguar Health Granted Extension Until May 15, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule; Company Announces Reverse Stock Split

27/04/2026 JAGX_US — Stock Titan

Jaguar Health turns to 1-for-35 reverse split to meet Nasdaq $1 rule

Las acciones de Jaguar comenzarán a cotizar sobre una base ajustada dividida el 30 de abril. La compañía necesita 10 días hábiles consecutivos por encima de 1 dólar antes del 15 de mayo para mantener su cotización en Nasdaq.

27/04/2026 JAGX_US — Investing.com

Jaguar Health receives Nasdaq extension, plans 1-for-35 reverse split

27/04/2026 JAGX_US — TipRanks

Jaguar Health Enacts Reverse Split to Maintain Nasdaq Listing

27/04/2026 JAGX_US — Stock Titan

Nasdaq grants Jaguar Health (NASDAQ: JAGX) extension as 1-for-35 reverse split starts

Jaguar Health obtiene una extensión de Nasdaq para cumplir con la regla del precio de oferta de $1,00 y aprueba una división inversa de acciones de 1 por 35 a partir del 30 de abril de 2026, para respaldar la cotización continua.

27/04/2026 JAGX_US — TradingView

Jaguar Health Disclosed Failure to Satisfy a Continued Listing Rule or Standard

27/04/2026 JAGX_US — Investing.com India

Jaguar Health receives Nasdaq extension, plans 1-for-35 reverse split

27/04/2026 JAGX_US — Investing.com UK

Jaguar Health receives Nasdaq extension, plans 1-for-35 reverse split

26/04/2026 JAGX_US — MSN ES ← EN

La oferta de acciones por valor de 1,5 millones de dólares de Jaguar Health genera revuelo en el sector minorista; Los comerciantes lo llaman una "oportunidad de caída"

Jaguar Health $1.5M Stock Offering Sparks Retail Buzz; Traders Call It A ‘Dip Opportunity’

25/04/2026 JAGX_US — MSN

Jaguar Health $1.5M Stock Offering Sparks Retail Buzz; Traders Call It A ‘Dip Opportunity’

25/04/2026 JAGX_US — MSN ES ← EN